Bergmann glia expression of polyglutamine-expanded ataxin-7 produces neurodegeneration by impairing glutamate transport-Reference-Cited by-同舟云学术

Bergmann glia expression of polyglutamine-expanded ataxin-7 produces neurodegeneration by impairing glutamate transport

Published:2006-08-27 Issue:10 Volume:9 Page:1302-1311
ISSN:1097-6256
Container-title:Nature Neuroscience
language:en
Short-container-title:Nat Neurosci

Author:

Custer Sara K,Garden Gwenn A,Gill Nishi,Rueb Udo,Libby Randell T,Schultz Christian,Guyenet Stephan J,Deller Thomas,Westrum Lesnick E,Sopher Bryce L,La Spada Albert R

Publisher

Springer Science and Business Media LLC

Subject

General Neuroscience

Link

http://www.nature.com/articles/nn1750.pdf

Reference49 articles.

1. Clement, A.M. et al. Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science 302, 113–117 (2003).

2. McGeer, P.L. et al. Microglia in degenerative neurological disease. Glia 7, 84–92 (1993).

3. Raeber, A.J. et al. Astrocyte-specific expression of hamster prion protein (PrP) renders PrP knockout mice susceptible to hamster scrapie. EMBO J. 16, 6057–6065 (1997).

4. Yazawa, I. et al. Mouse model of multiple system atrophy alpha-synuclein expression in oligodendrocytes causes glial and neuronal degeneration. Neuron 45, 847–859 (2005).

5. Forman, M.S. et al. Transgenic mouse model of tau pathology in astrocytes leading to nervous system degeneration. J. Neurosci. 25, 3539–3550 (2005).

Cited by 207 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endocytic adaptor AP-2 maintains Purkinje cell function by balancing cerebellar parallel and climbing fiber synapses;2024-06-02

2. Altered Metabolic Signaling and Potential Therapies in Polyglutamine Diseases;Metabolites;2024-05-31

3. Optogenetic and chemogenetic approaches for modeling neurological disorders in vivo;Progress in Neurobiology;2024-04

4. Reduced Bergmann glial process terminations and lateral appendages in essential tremor;Annals of Clinical and Translational Neurology;2023-12-14

5. Development of a Polymeric Pharmacological Nanocarrier System as a Potential Therapy for Spinocerebellar Ataxia Type 7;Cells;2023-11-30